Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSun sensitivity is not listed as a recognised side effect of semaglutide (Wegovy) in the UK prescribing information, but a meaningful number of people starting treatment do notice their skin reacting more than usual to sunlight. Here is what is known, what is likely going on, and when it is worth mentioning to your prescriber. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been on Wegovy for six or eight weeks, things are going well, and then you spend a Saturday afternoon in the garden only to find your shoulders are redder than you'd expect. Your first instinct is to wonder whether the injection is to blame. That instinct is understandable, and the question is worth taking seriously rather than dismissing.
The honest answer is that photosensitivity (the technical term for an increased skin reaction to UV light) does not appear in the Wegovy Summary of Product Characteristics as a recognised adverse effect. The NHS semaglutide medicines page covers the side-effect profile in plain language, and increased sun sensitivity is not on the list. So if you are expecting a stark clinical warning on the leaflet, you will not find one.
What you will find reported informally, across patient communities, is that skin can feel more reactive during treatment. The reasons for this are likely indirect rather than a direct drug effect on skin cells. Understanding those indirect routes is more useful than assuming the question has a simple yes-or-no answer. One common misconception is that Wegovy contains a chemical that makes you photosensitive the way certain antibiotics or diuretics do. It does not work like that, let that one go.
Wegovy's most widely reported side effects are gastrointestinal: nausea, loose stools, and reduced appetite are common, particularly after starting or moving to a higher dose. These are detailed in the NHS guidance and in the MHRA's prescribing information. When nausea reduces how much you drink and eat, mild dehydration can follow. Dehydrated skin is less resilient, it recovers more slowly from UV exposure and may feel tighter, redder, or more prone to peeling after time outside.
There is also the matter of weight loss itself. As body composition changes over months of treatment, the distribution of subcutaneous fat alters, which can subtly affect how the skin sits and how it responds to environmental stressors including sunlight. Some people notice their skin is generally more sensitive during rapid weight loss (drier, thinner-feeling in places) which can make sun exposure seem harsher even without any direct drug action on melanin or UV response.
A smaller group of people on semaglutide report injection-site skin reactions (redness, itching, mild swelling) and occasionally more diffuse skin changes. Anyone experiencing these should consult their prescriber. You can read about related skin responses on our sensitive skin on Wegovy page and our Wegovy skin sensitivity overview. Reporting unexpected skin reactions through the MHRA's Yellow Card scheme helps build the post-market evidence base for newer medicines like Wegovy, which carries a Black Triangle (▼) status signalling active safety monitoring.
The practical response does not require stopping treatment. A few straightforward adjustments make a real difference. Keep up fluid intake throughout the day, particularly if nausea has made eating and drinking less consistent. SPF 30 or higher, applied before going outdoors, is sensible for anyone, and more so if your skin feels more reactive than usual. Loose, breathable clothing that covers your shoulders and upper arms reduces UV load without adding heat.
If you are curious about other sensory or perceptual changes reported during semaglutide treatment, our Wegovy light sensitivity page addresses visual and light-related experiences separately. Changes in smell perception during GLP-1 treatment are covered on the semaglutide smell sensitivity page, a less-expected aspect of treatment that catches some people off guard.
The key clinical point: if you develop a rash, hives, significant facial swelling or any sign of an allergic reaction, seek medical attention promptly. Those are different from mild sunburn and need a clinical assessment the same day.
Not every skin change needs an urgent call, but certain situations do. Tell your prescriber if you notice persistent skin redness not explained by sun exposure, a new rash appearing shortly after a dose, swelling around the injection site that is spreading, or any change that is worsening rather than settling. These could be unrelated to semaglutide entirely, or they could be a signal worth documenting.
The broader context of how semaglutide affects the body (including the evidence on insulin sensitivity and metabolic effects) is explored on our semaglutide and insulin sensitivity page for anyone whose curiosity extends beyond the skin question.
If you are weighing up whether Wegovy is right for you and what the full treatment picture looks like, our weight management treatment overview is a useful starting point. For anyone thinking about cost as part of that decision, the cost of Wegovy in the UK page lays out what private treatment realistically involves. And when you are ready to speak to a prescriber, starting a free consultation with our clinical team is how that conversation begins.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.